Data / Medical devices / United States / Life Technologies Corporation
Life Technologies Corporation: FDA-registered device maker in Carlsbad, CA, United States, 2 PMA approvals
Life Technologies Corporation is registered with the FDA (registration 3007287152) in Carlsbad, CA, United States. It lists 4 device types. The FDA files 2 PMA approvals under its listings, the newest dated July 2, 2025. Registered through 2026. FDA data exported November 3, 2026.
SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.
- FDA registration number
- 3007287152
- Address
- 5781 Van Allen Way, Carlsbad, CA, United States, 92008
- Owner or operator
- Life Technologies Corporation (9915045)
- Roles
- Specification developer
- First device listed
- September 17, 2014
- Registered through
- 2026
- Brand names listed
- 3500 Dx Capillary Array 50-cm, 3500 Dx Series 96-Well Fast (0.1mL) Retainer & Base Set, 3500 Dx Series 96-Well Standard Retainer & Base Set, 3500xL Dx Capillary Array 50-cm, 96-Well Septa Dx, Anode Buffer Container Dx, CBC Wash Septa Clip Dx, Cathode Buffer Container Dx and more
Devices it lists
| Device | Product code | Class | Role | Source |
|---|---|---|---|---|
| Clinical Sample Concentrator | JJH | 1 | Specification developer | accessdata.fda.gov |
| High Throughput Dna Sequence Analyzer | PFF | 2 | Specification developer | accessdata.fda.gov |
| Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System | PQP | 3 | Specification developer | accessdata.fda.gov |
| Reagents For Molecular Diagnostic Test Systems | PFT | 1 | Specification developer | accessdata.fda.gov |
PMA approvals
Premarket approvals this establishment lists, with the supplements the FDA has decided since.
| Approved | PMA number | Device | Product code | Supplements | Latest decision | Source |
|---|---|---|---|---|---|---|
| July 2, 2025 | P240040 | Oncomine Dx Express Test | PQP | 5 | September 9, 2026 | accessdata.fda.gov |
| June 22, 2017 | P160045 | Oncomine Dx Target Test | PQP | 44 | March 4, 2026 | accessdata.fda.gov |
Compare with other makers
- All makers of Reagents For Molecular Diagnostic Test Systems
- All makers of Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System
- All makers of Clinical Sample Concentrator
- All makers of High Throughput Dna Sequence Analyzer
Updated September 9, 2026. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.